Development of lipid nanoparticle mRNA vaccines against swine influenza

Swine influenza A viruses (IAV-S) cause highly contagious respiratory disease in pigs and pose zoonotic risk due to bidirectional transmission between humans and swine. Managing IAV-S, particularly the H1 subtype, in pigs is vital both to prevent interspecies transmission and to protect the swine industry. Lipid nanoparticle (LNP)-encapsulated mRNA vaccines encoding specific viral antigens offer a rapid, adaptable platform well-suited for targeting rapidly evolving influenza strains. Hemagglutinin (HA), the viral protein that initiates infection, is a critical target for vaccination due to its central role in influenza infection and its antigenic diversity. This study aimed to design and generate three mRNA-LNP vaccine candidates encoding distinct HA antigens: a Taiwan porcine H1, a swine-to-human H1, and a consensus H1. We then evaluated the immunogenicity and cross-reactive potential of these candidates in a mouse model. In vivo evaluation demonstrated that the swine-to-human H1 vaccine candidate induced the broadest humoral IgG response across all three HA antigens, whereas the Taiwan porcine H1 candidate elicited the narrowest cross-reactive immunity. Serum derived from mice-immunized with all three candidate vaccines neutralized the Taiwan porcine H1N2 virus to varying degrees. However, neither intramuscular nor intranasal administration induced mucosal immunity. These results suggest while the swine-to-human HA construct shows strong potential for providing broad systemic immunity, the consensus HA construct requires further optimization. An effective swine influenza vaccine strategy may require a combined intramuscular and intranasal approach to ensure comprehensive systemic and mucosal immunity, including the induction of broadly neutralizing antibodies. Further analysis of the cross-protection and cellular immunity elicited by these candidates is necessary.

Authors

Institutions

Publication Details

Journal
BMC Veterinary Research
Published
2026-11-13
DOI
https://doi.org/10.1186/s12917-026-06097-0
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of lipid nanoparticle mRNA vaccines against swine influenza

Yen-Chen Chang, Yumian Lai, Hui‐Wen Chang, Hui-Wen Chen et al.
5 links
BMC Veterinary Research
Influenza Virus Research Studies
article

Development of lipid nanoparticle mRNA vaccines against swine influenza

Yen-Chen Chang, Yumian Lai, Hui‐Wen Chang, Hui-Wen Chen, Sophia B. Scobell
article en

Abstract

Swine influenza A viruses (IAV-S) cause highly contagious respiratory disease in pigs and pose zoonotic risk due to bidirectional transmission between humans and swine. Managing IAV-S, particularly the H1 subtype, in pigs is vital both to prevent interspecies transmission and to protect the swine industry. Lipid nanoparticle (LNP)-encapsulated mRNA vaccines encoding specific viral antigens offer a rapid, adaptable platform well-suited for targeting rapidly evolving influenza strains. Hemagglutinin (HA), the viral protein that initiates infection, is a critical target for vaccination due to its central role in influenza infection and its antigenic diversity. This study aimed to design and generate three mRNA-LNP vaccine candidates encoding distinct HA antigens: a Taiwan porcine H1, a swine-to-human H1, and a consensus H1. We then evaluated the immunogenicity and cross-reactive potential of these candidates in a mouse model. In vivo evaluation demonstrated that the swine-to-human H1 vaccine candidate induced the broadest humoral IgG response across all three HA antigens, whereas the Taiwan porcine H1 candidate elicited the narrowest cross-reactive immunity. Serum derived from mice-immunized with all three candidate vaccines neutralized the Taiwan porcine H1N2 virus to varying degrees. However, neither intramuscular nor intranasal administration induced mucosal immunity. These results suggest while the swine-to-human HA construct shows strong potential for providing broad systemic immunity, the consensus HA construct requires further optimization. An effective swine influenza vaccine strategy may require a combined intramuscular and intranasal approach to ensure comprehensive systemic and mucosal immunity, including the induction of broadly neutralizing antibodies. Further analysis of the cross-protection and cellular immunity elicited by these candidates is necessary.

BMC Veterinary Research
National Taiwan University (TW)
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon